144 related articles for article (PubMed ID: 17084902)
1. Fluconazole susceptibility testing of Candida species by flow cytometry.
Joung YH; Kim HR; Lee MK; Park AJ
J Infect; 2007 May; 54(5):504-8. PubMed ID: 17084902
[TBL] [Abstract][Full Text] [Related]
2. Rapid flow-cytometric susceptibility testing of Candida species.
Rudensky B; Broidie E; Yinnon AM; Weitzman T; Paz E; Keller N; Raveh D
J Antimicrob Chemother; 2005 Jan; 55(1):106-9. PubMed ID: 15546969
[TBL] [Abstract][Full Text] [Related]
3. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
J Clin Microbiol; 2007 Mar; 45(3):796-802. PubMed ID: 17215344
[TBL] [Abstract][Full Text] [Related]
4. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
Claudino AL; Peixoto RF; Melhem MS; Szeszs MW; Lyon JP; Chavasco JK; Franco MC
Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
Fleck R; Dietz A; Hof H
J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
[TBL] [Abstract][Full Text] [Related]
6. Direct fluconazole susceptibility testing of positive Candida blood cultures by flow cytometry.
Rudensky B; Broide E; Berko N; Wiener-Well Y; Yinnon AM; Raveh D
Mycoses; 2008 May; 51(3):200-4. PubMed ID: 18399900
[TBL] [Abstract][Full Text] [Related]
7. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
Lee SC; Lo HJ; Fung CP; Lee N; See LC
J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
[TBL] [Abstract][Full Text] [Related]
8. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
Pfaller MA; Hazen KC; Messer SA; Boyken L; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2004 Aug; 42(8):3607-12. PubMed ID: 15297505
[TBL] [Abstract][Full Text] [Related]
9. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome.
Wenisch C; Moore CB; Krause R; Presterl E; Pichna P; Denning DW
J Clin Microbiol; 2001 Jul; 39(7):2458-62. PubMed ID: 11427554
[TBL] [Abstract][Full Text] [Related]
11. Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.
Ostrosky-Zeichner L; Rex JH; Pfaller MA; Diekema DJ; Alexander BD; Andes D; Brown SD; Chaturvedi V; Ghannoum MA; Knapp CC; Sheehan DJ; Walsh TJ
Antimicrob Agents Chemother; 2008 Nov; 52(11):4175-7. PubMed ID: 18809944
[TBL] [Abstract][Full Text] [Related]
12. [Fluconazole susceptibility of invasive Candida sp isolates as determined by three methods: Bogotá - Colombia].
Torres D NA; Alvarez M CA; Rondón S MA
Rev Chilena Infectol; 2009 Apr; 26(2):135-43. PubMed ID: 19621144
[TBL] [Abstract][Full Text] [Related]
13. Determination of the minimum inhibitory concentration of Cryptococcus neoformans and Cryptococcus gattii against fluconazole by flow cytometry.
Morales BP; Junior IN; Trilles L; Bertho AL; Oliveira Rde V; Nishikawa MM; Elias Mdos S; Wanke B; Lazéra Mdos S
Med Mycol; 2014 Jan; 52(1):90-8. PubMed ID: 23808405
[TBL] [Abstract][Full Text] [Related]
14. [Disk diffusion method for fluconazole susceptibility testing of Candida spp. isolates].
Rodero L; Córdoba S; Vivot W; Campo M; Corfield P; Olguín C; Cuirolo A; Soria M; Guelfand L; Canteros CE; Davel G;
Rev Argent Microbiol; 2006; 38(3):155-63. PubMed ID: 17152217
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibilities to yeasts using the ATB FUNGUS 2 method, compared with Sensititre Yeast One and standard CLSI (NCCLS) M27-A2 methods.
Torres-Rodríguez JM; Alvarado-Ramírez E
J Antimicrob Chemother; 2007 Sep; 60(3):658-61. PubMed ID: 17623690
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the disc diffusion method with a comparison study for fluconazole susceptibility of Candida strains.
Kustimur S; Kalkanci A; Mansuroglu H; Senel K
Chin Med J (Engl); 2003 Apr; 116(4):633-6. PubMed ID: 12875738
[TBL] [Abstract][Full Text] [Related]
18. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Meis JF; Gould IM; Fu W; Colombo AL; Rodriguez-Noriega E;
J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
[TBL] [Abstract][Full Text] [Related]
19. Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Sep; 65(1):27-34. PubMed ID: 19679232
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility testing of Candida albicans by flow cytometry.
Gökahmetoglu S; Nedret Koç A; Patiroglu T
Mycoses; 2003 Sep; 46(8):307-11. PubMed ID: 12950899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
